tiprankstipranks
Blurbs

Analysts Are Bullish on Top Healthcare Stocks: Sensus Healthcare (SRTS), Keros Therapeutics (KROS)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Sensus Healthcare (SRTSResearch Report), Keros Therapeutics (KROSResearch Report) and Alphatec Holdings (ATECResearch Report) with bullish sentiments.

Sensus Healthcare (SRTS)

H.C. Wainwright analyst Yi Chen reiterated a Buy rating on Sensus Healthcare today and set a price target of $16.00. The company’s shares closed last Thursday at $11.13, close to its 52-week high of $11.96.

According to TipRanks.com, Chen is ranked 0 out of 5 stars with an average return of -9.7% and a 35.1% success rate. Chen covers the Healthcare sector, focusing on stocks such as Interpace Diagnostics Group, HTG Molecular Diagnostics, and EyePoint Pharmaceuticals.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Sensus Healthcare with a $14.17 average price target.

See Insiders’ Hot Stocks on TipRanks >>

Keros Therapeutics (KROS)

In a report released today, Andrew Fein from H.C. Wainwright reiterated a Buy rating on Keros Therapeutics, with a price target of $100.00. The company’s shares closed last Thursday at $33.12.

According to TipRanks.com, Fein is currently ranked with 0 stars on a 0-5 stars ranking scale, with an average return of -11.2% and a 37.2% success rate. Fein covers the Healthcare sector, focusing on stocks such as DBV Technologies SA – American, Amylyx Pharmaceuticals Inc, and Global Blood Therapeutics.

Currently, the analyst consensus on Keros Therapeutics is a Strong Buy with an average price target of $95.00, which is a 186.4% upside from current levels. In a report issued on July 26, BTIG also initiated coverage with a Buy rating on the stock with a $80.00 price target.

Alphatec Holdings (ATEC)

In a report released today, Sean Lee CFA from H.C. Wainwright maintained a Buy rating on Alphatec Holdings, with a price target of $20.00. The company’s shares closed last Thursday at $8.21.

According to TipRanks.com, CFA is currently ranked with 0 stars on a 0-5 stars ranking scale, with an average return of -14.9% and a 22.7% success rate. CFA covers the Healthcare sector, focusing on stocks such as Monopar Therapeutics Inc, CASI Pharmaceuticals, and Virios Therapeutics.

Currently, the analyst consensus on Alphatec Holdings is a Strong Buy with an average price target of $14.80, implying a 79.1% upside from current levels. In a report released today, Needham also reiterated a Buy rating on the stock with a $13.00 price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on SRTS:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More